Stock listing

HKEX:2652 CF PharmTech. Inc. (長風藥業) 股價

Follow CF PharmTech. Inc. into a list and get an email when it puts out news.

Share price · HKEX:2652

$4.22 HKD -0.21 (-4.8%)

Close on Nov 20, 2026

Past year -87.4% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$4.16 – $4.45 HKDNov 20, 2026
Volume
1.32M sharesNov 20, 2026
Market cap
$1.36B HKDAt the close on Nov 20, 2026 · price × 322.4M shares outstanding
52-week range
$4.16 – $39.50 HKDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$25.24M HKDMedian day 1.87M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
CF PharmTech. Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · HKEX:2652 · HKD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$4.22-0.215-4.8%$4.395$4.45$4.161,318,384
$4.435-0.21-4.5%$4.525$4.69$4.29936,300
$4.645+0.055+1.2%$4.75$4.75$4.515874,707
$4.59-0.25-5.2%$4.84$4.84$4.4951,106,148
$4.84-0.24-4.7%$5.10$5.105$4.84835,600
$5.08-0.12-2.3%$5.19$5.225$5.065767,900
$5.20+0.015+0.3%$5.29$5.295$5.111,037,100
$5.185+0.145+2.9%$5.02$5.26$5.02863,900
$5.04-0.12-2.3%$5.245$5.335$5.0051,075,100
$5.16-0.315-5.8%$5.47$5.49$5.1551,011,800
$5.475+0.19+3.6%$5.32$5.58$5.301,944,100
$5.285+0.215+4.2%$4.95$5.325$4.931,227,207
$5.07-0.215-4.1%$5.08$5.24$4.9351,881,675
$5.285-0.015-0.3%$5.30$5.30$5.115713,143
$5.30-0.33-5.9%$5.76$5.775$5.271,007,900
$5.63-0.005-0.1%$5.635$5.875$5.551,142,875
$5.635+0.01+0.2%$5.62$5.77$5.57539,546
$5.625+0.015+0.3%$5.555$5.68$5.53396,974
$5.61+0.015+0.3%$5.35$5.65$5.35390,245
$5.595+0.165+3.0%$5.43$5.595$5.33792,083
$5.43-0.325-5.6%$5.755$5.755$5.3751,075,343
$5.755-0.075-1.3%$5.86$6.025$5.6251,257,800
$5.83-0.15-2.5%$6.15$6.15$5.8051,497,800
$5.98+0.07+1.2%$6.15$6.15$5.771,957,000
$5.91-0.265-4.3%$6.035$6.25$5.912,289,100
$6.175-0.175-2.8%$6.405$6.505$6.0454,992,300
$6.35+0.23+3.8%$6.00$6.69$5.917,910,300
$6.12+0.065+1.1%$6.235$6.325$5.882,415,200
$6.055+0.305+5.3%$5.75$6.43$5.57510,319,300
$5.75-0.89-13.4%$6.64$6.645$5.17525,334,504
$6.64-0.245-3.6%$6.80$6.88$6.35996,400
$6.885-0.275-3.8%$7.175$7.175$6.805434,100
$7.16+0.31+4.5%$7.18$7.30$6.655625,300
$6.85-0.085-1.2%$7.30$7.30$6.85400,200
$6.935-0.05-0.7%$7.06$7.15$6.512,613,100
$6.985-0.305-4.2%$7.305$7.49$6.923,160,600
$7.29-2.20-23.2%$9.49$9.49$7.2655,086,900
$9.49+0.115+1.2%$9.375$9.55$9.07250,800
$9.375-0.01-0.1%$9.285$9.73$9.211,983,600
$9.385-0.915-8.9%$10.33$10.38$9.322,711,000
$10.30-0.70-6.4%$11.29$11.29$9.9851,632,500
$11.000.000.0%$10.77$11.28$10.681,855,900
$11.00+0.37+3.5%$10.63$11.30$10.632,071,300
$10.63+0.25+2.4%$10.48$10.78$10.231,268,200
$10.38+0.32+3.2%$10.06$10.65$9.871,988,000
$10.06-0.06-0.6%$9.82$10.70$9.822,075,800
$10.12-0.24-2.3%$10.45$11.49$9.944,586,400
$10.36+0.76+7.9%$9.695$10.65$9.6055,751,050
$9.60+0.315+3.4%$9.285$9.80$8.883,535,000
$9.285-0.685-6.9%$10.08$10.09$9.202,488,600
$9.97-0.37-3.6%$10.34$10.50$9.912,032,700
$10.34-0.66-6.0%$10.88$10.92$10.143,609,700
$11.00-0.80-6.8%$12.05$12.05$10.923,185,900
$11.80-0.90-7.1%$12.72$12.80$11.752,449,600
$12.70-1.10-8.0%$13.98$13.98$12.701,857,900
$13.80-0.29-2.1%$14.30$14.32$13.791,296,000
$14.09-0.42-2.9%$14.63$14.63$13.362,206,300
$14.51-0.87-5.7%$15.38$15.66$14.154,495,200
$15.38+0.07+0.5%$15.49$18.66$15.3611,403,700
$15.31-0.32-2.0%$15.63$15.96$15.291,284,100
$15.63+0.42+2.8%$16.78$19.00$15.409,570,100
$15.21+0.01+0.1%$15.25$15.35$15.003,104,000
$15.20-0.67-4.2%$15.91$16.05$15.192,773,800
$15.87-0.53-3.2%$16.40$16.79$15.873,213,200
Ticker
HKEX:2652
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
HKEX
Currency
HKD

What changed lately

Latest news

All CF PharmTech. Inc. news

CF PharmTech. Inc. on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
16 in the last 12 months · 16 in all · newest Nov 4, 2026 · oldest 2026

Valuation

P/E 466× against a median of 23.3×: the highest of 11 Pharmaceuticals companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$899.1M HKD
P/E
466×
EV/sales
1.8×
EV/EBITDA
12.4×
Price/book
0.9×
Gross margin
75.8%
Operating margin
−1.6%
Net margin
0.6%
Debt to equity
0.1×
Beta
No index for this market yet

Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
CF PharmTech. Inc. Class H · HKEX:2652US$173.6MUS$114.7M466×1.8×12.4×0.9×0.6%0.1×n/a
JW Holdings Corporation · KRX:096760US$187.0MUS$109.7M3.0×0.1×0.6×0.9×8.3%0.0×n/a
NGL Fine-Chem Ltd. · NSE:NGLFINEUS$183.2MUS$183.2M29.7×3.2×20.2×5.2×10.7%0.0×n/a
Beta Drugs Ltd. · NSE:BETAUS$181.1MUS$180.3M36.8×4.1×20.1×6.9×11.1%0.5×n/a
Sinphar Pharmaceutical Co. Ltd. · TWSE:1734US$179.9MUS$193.6M16.9×1.9×9.6×1.7×10.2%0.6×n/a
Golden Throat Holdings Group Co Ltd · HKEX:6896US$177.8MUS$121.9M4.7×0.9×2.4×1.0×26.6%0.6×n/a
SIGA Technologies Inc. · NASDAQ:SIGAUS$172.5MUS$56.35M251×1.1×n/a1.1×1.3%0.0×1.01
Searle Company Ltd · PSX:SEARLUS$169.6MUS$163.7M68.6×1.2×6.4×1.4×1.8%0.0×n/a
Dawnrays Pharmaceutical Holdings Ltd. · HKEX:2348US$165.1M−US$72.72M5.2×−0.4×−1.4×0.3×17.4%0.0×n/a
SCI Pharmtech Corp. · TWSE:4119US$164.3MUS$193.9M90.0×5.1×17.8×1.0×4.8%0.2×n/a
Binh Dinh Pharmaceutical & Medical Equipment JSC · HOSE:DBDUS$161.0MUS$149.0M13.2×2.0×10.5×2.3×16.6%0.1×n/a
Median of the othersUS$175.1MUS$156.3M23.3×1.5×9.6×1.2×10.4%0.1×1.01

Events

QuarterResults
Q2 2025Sep 25, 2025

Open Events

Financials

Annual, in CNY

Income statement

LineFY2025FY2024FY2023FY2022
Revenue432.5M607.8M556.4M349.1M
Cost of revenue104.6M116.4M98.9M81.7M
Gross profit327.9M491.4M457.5M267.5M
Research and development124.5M307.5M302.4M203.1M
Selling, general and administrative218.3M366.0M323.5M247.0M
Operating income-6.89M21.0M22.7M-70.5M
Depreciation and amortization68.5M48.3M42.4M33.9M
EBITDA61.6M69.3M65.1M-36.5M
Interest expense2.54M8.99M13.2M13.7M
Income before tax-13.4M19.2M22.4M-70.6M
Net income2.48M21.1M31.7M-49.4M
Earnings per share, basic0.010.050.08-0.12

Balance sheet

LineFY2025FY2024FY2023FY2022
Cash and equivalents414.9M81.9M70.6M74.8M
Short-term investments238.3M266.1M330.8M346.1M
Receivables128.6M27.1M2.87M8.94M
Inventory36.7M47.2M36.1M28.3M
Current assets890.2M462.2M495.0M484.3M
Property, plant and equipment562.3M430.4M328.5M
Total assets1.78B1.26B1.14B1.02B
Accounts payable21.4M20.6M27.2M13.1M
Current liabilities194.0M245.6M171.5M137.2M
Long-term debt97.8M55.4M19.2M0
Total liabilities307.9M319.7M225.1M153.3M
Shareholders' equity1.47B939.3M910.0M861.9M
Shares outstanding411.9M412.0M412.0M412.0M

Cash flow

LineFY2025FY2024FY2023FY2022
Cash from operations-110.3M96.5M116.3M45.5M
Capital spending-151.1M-200.6M-138.3M-120.6M
Free cash flow-261.4M-104.2M-22.0M-75.1M
Cash from investing-113.4M-127.7M-151.4M
Cash from financing28.7M7.88M-5.41M
Share buybacks-2.09M0
Change in cash337.3M11.3M-4.23M-108.4M

Open Financials

Filings

FilingDateTypeFiled with
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026Nov 4, 2026Monthly returnHKEX
NEXT DAY DISCLOSURE RETURNOct 8, 2026Next day disclosure returnHKEX
NEXT DAY DISCLOSURE RETURNOct 7, 2026Next day disclosure returnHKEX
NEXT DAY DISCLOSURE RETURNOct 6, 2026Next day disclosure returnHKEX
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026Oct 6, 2026Monthly returnHKEX
VOLUNTARY ANNOUNCEMENT VOLUNTARY EXTENSION OF LOCK-UP PERIOD FOR SHARES HELD BY CORE MANAGEMENT BY SIX MONTHSOct 5, 2026Other filingsHKEX
NEXT DAY DISCLOSURE RETURNOct 5, 2026Next day disclosure returnHKEX
NEXT DAY DISCLOSURE RETURNOct 2, 2026Next day disclosure returnHKEX
2026 Interim ReportSep 30, 2026Interim reportHKEX
NEXT DAY DISCLOSURE RETURNSep 30, 2026Next day disclosure returnHKEX
All 16 filings
FilingDateTypeFiled with
NEXT DAY DISCLOSURE RETURNSep 29, 2026Next day disclosure returnHKEX
NEXT DAY DISCLOSURE RETURNSep 28, 2026Next day disclosure returnHKEX
VOLUNTARY ANNOUNCEMENT ICF004 COMPLETES ENROLMENT AND DOSING OF FIRST HEALTHY VOLUNTEER IN PHASE I CLINICAL TRIALSep 21, 2026Other filingsHKEX
List of Directors and their Roles and FunctionsJun 26, 2026List of directorsHKEX
CHANGE IN BOARD LOT SIZEJun 22, 2026Other filingsHKEX
NEXT DAY DISCLOSURE RETURNJun 16, 2026Next day disclosure returnHKEX

Open Filings

Cap table

Built by 6ix from CF PharmTech. Inc. Class H’s releases

Common shares
322,381,086
Fully diluted
322,381,086

Fully diluted

LineShares
Common shares322,381,086

Share count over time

CountShares
Nov 22, 2026322,381,086

Open Cap table

Shareholders

Insider trades

TradeTradeSharesPriceValueDate
LIANG Bill Wenqing
Director or chief executive
Buy19,300HKD 6.92HKD 134KOct 6, 2026
LIANG Bill Wenqing
Director or chief executive
Buy25,100HKD 7.29HKD 183KSep 28, 2026

Open Shareholders

Log in to ask 6ix AI your own questions about CF PharmTech. Inc.